Influence of obesity in central blood pressure

Gernot Pichler1, Fernando Martinez, Antonio Vicente

  • 1aHypertension Clinic, Department of Internal Medicine, Clinical Hospital of Valencia, INCLIVA, University of Valencia bCIBEROBn, Carlos III Health Institute, Madrid, Spain cCardiovascular Risk Unit, Department of Pediatrics, General Hospital of Valencia, University of Valencia, Valencia, Spain.

Journal of Hypertension
|November 8, 2014
PubMed

Insights

Overweight and obese patients have lower central systolic blood pressure (SBP) and pulse wave velocity (PWV) compared to normal-weight individuals. This finding suggests a complex relationship between body mass index (BMI) and cardiovascular dynamics.

Area of Science:

  • Cardiovascular Science
  • Obesity Research
  • Vascular Physiology

Background:

  • Obesity is a significant global health concern and a major risk factor for cardiovascular disease.
  • Understanding the impact of body mass index (BMI) on cardiovascular parameters is crucial for risk assessment.

Purpose of the Study:

  • To investigate the influence of BMI on central blood pressure (BP) and pulse wave velocity (PWV).
  • To compare these effects in both normotensive and hypertensive patient groups.

Main Methods:

  • Peripheral BP measured using an oscillometric device.
  • Central aortic BP reconstructed from radial artery waveforms.
  • Carotid-femoral pulse wave velocity (PWV) measured using an automatic device.

Main Results:

  • Central SBP showed a negative association with overweight/obesity (BMI ≥25 kg/m²).
  • PWV decreased in overweight/obese patients compared to normal-weight patients at similar central SBP levels.
  • PWV was positively associated with age, male sex, and BP treatment.

Conclusions:

  • Overweight and obesity are associated with lower central SBP, particularly in women.
  • Further research is needed to understand the clinical implications of body weight on vascular dynamics.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
352
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
431
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
7.9K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
310
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.9K